Ueda-Consolvo, T., Ishida, M., Nakamura, T., Yanagisawa, S., Tsuboi, K., Wakabayashi, T., … International Retina Biosimilar Study Group (Inter BIOS Group). (2024). Biosimilar ranibizumab (BS1) - early experience from Japan (BRIJ study). Eye (Lond), 38(16), 3193–3196. https://doi.org/10.1038/s41433-024-03220-z

Ueda-Consolvo, Tomoko, Masaaki Ishida, Tomoko Nakamura, Shuichiro Yanagisawa, Kotaro Tsuboi, Taku Wakabayashi, Atsushi Hayashi, Ashish Sharma, and International Retina Biosimilar Study Group (Inter BIOS Group). “Biosimilar ranibizumab (BS1) - early experience from Japan (BRIJ study).” Eye (Lond) 38, no. 16 (November 2024): 3193–96. https://doi.org/10.1038/s41433-024-03220-z.

Ueda-Consolvo T, Ishida M, Nakamura T, Yanagisawa S, Tsuboi K, Wakabayashi T, et al. Biosimilar ranibizumab (BS1) - early experience from Japan (BRIJ study). Eye (Lond). 2024 Nov;38(16):3193–6.

Ueda-Consolvo, Tomoko, et al. “Biosimilar ranibizumab (BS1) - early experience from Japan (BRIJ study).” Eye (Lond), vol. 38, no. 16, Nov. 2024, pp. 3193–96. Pubmed, doi:10.1038/s41433-024-03220-z.

Ueda-Consolvo T, Ishida M, Nakamura T, Yanagisawa S, Tsuboi K, Wakabayashi T, Hayashi A, Sharma A, International Retina Biosimilar Study Group (Inter BIOS Group). Biosimilar ranibizumab (BS1) - early experience from Japan (BRIJ study). Eye (Lond). 2024 Nov;38(16):3193–3196.